These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 8004315

  • 1. Pulmonary function abnormalities in thalassemia major and the role of iron overload.
    Factor JM, Pottipati SR, Rappoport I, Rosner IK, Lesser ML, Giardina PJ.
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1570-4. PubMed ID: 8004315
    [Abstract] [Full Text] [Related]

  • 2. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S, Pathare AV.
    Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
    [Abstract] [Full Text] [Related]

  • 3. Pulmonary Functions in Children With Thalassemia Major.
    Ozyoruk D, Misirlioglu ED.
    J Pediatr Hematol Oncol; 2015 Nov; 37(8):605-10. PubMed ID: 26422288
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.
    Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, Allen CJ, Farrell DE, Harris JW.
    N Engl J Med; 1994 Sep 01; 331(9):567-73. PubMed ID: 8047080
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Program of hypertransfusion and chelation with desferrioxamine in 10 patients with thalassemia major].
    Albo C, Cabrera J, Dios A, Castro M, Ares C, Constenla I, López D.
    Sangre (Barc); 1995 Dec 01; 40(6):441-5. PubMed ID: 8850225
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pulmonary dysfunction in transfusion-dependent patients with thalassemia major.
    Carnelli V, D'Angelo E, Pecchiari M, Ligorio M, D'Angelo E.
    Am J Respir Crit Care Med; 2003 Jul 15; 168(2):180-4. PubMed ID: 12738605
    [Abstract] [Full Text] [Related]

  • 14. Comparison of oral and subcutaneous iron chelation therapies in the prevention of major endocrinopathies in beta-thalassemia major patients.
    Wang CH, Wu KH, Tsai FJ, Peng CT, Tsai CH.
    Hemoglobin; 2006 Jul 15; 30(2):257-62. PubMed ID: 16798651
    [Abstract] [Full Text] [Related]

  • 15. Combined iron chelation therapy.
    Galanello R, Agus A, Campus S, Danjou F, Giardina PJ, Grady RW.
    Ann N Y Acad Sci; 2010 Aug 15; 1202():79-86. PubMed ID: 20712777
    [Abstract] [Full Text] [Related]

  • 16. Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience.
    El-Beshlawy A, Manz C, Naja M, Eltagui M, Tarabishi C, Youssry I, Sobh H, Hamdy M, Sharaf I, Mostafa A, Shaker O, Hoffbrand AV, Taher A.
    Ann Hematol; 2008 Jul 15; 87(7):545-50. PubMed ID: 18351337
    [Abstract] [Full Text] [Related]

  • 17. Desferrioxamine induced urinary iron excretion in thalassemia.
    Dubey AP, Kumar S, Choudhury P, Talukdar B, Puri RK.
    Indian Pediatr; 1993 Jun 15; 30(6):775-8. PubMed ID: 8132258
    [Abstract] [Full Text] [Related]

  • 18. Lungs in thalassaemia major patients receiving regular transfusion.
    Tai DY, Wang YT, Lou J, Wang WY, Mak KH, Cheng HK.
    Eur Respir J; 1996 Jul 15; 9(7):1389-94. PubMed ID: 8836648
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.